How Are Gilead Sciences’ Revenues Trending in 2019?

How Are Gilead Sciences’ Revenues Trending in 2019?

In its first-quarter earnings investor presentation, Gilead Sciences (GILD) has projected fiscal 2019 product sales of $21.30 billion to $21.80 billion. Wall Street analysts have forecasted the company’s fiscal 2019 revenues to be $22.05 billion, a YoY decline of 0.36%.